THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Biogen enters agreement to acquire RayThera and advance immunology assets
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Biogen and RayThera announced a definitive acquisition agreement under which Biogen would acquire RayThera’s immunology portfolio, with Biogen expected to lead development, manufacturing and global commercialization after closing.
- Current status
- Official collaboration
- Known availability
- The official source confirms the collaboration; timing details remain under review.
- Place
- Cambridge, Massachusetts; San Diego, California, United States
- Source checked
- September 9, 2026
FOLLOW THE STORY